Catalyst Wire Dossier Catalyst Wire Dossier

Gemtuzumab

gemtuzumab ozogamicin
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Gemtuzumab, covering 2014-07-18 to 2017-12-22. Get the full timeline:

Most recent: Clinical Trial Update: S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia [Phase 2]

See pricing